TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Marjorie Tingley’s sons and her Michigan memory care facility disagreed over medication for her dementia-related agitation, according to records and a pending lawsuit. The facility denies the family’s allegations that it sent her to the emergency room in retaliation; a trial on the remaining claims is scheduled for early next year if mediation fails.
Marjorie Tingley’s sons fought a Michigan memory care facility’s requests to medicate their mother for dementia-related agitation, and later sued the facility over her care, repeated emergency room trips and eviction. Vista Grande Villa denies the family’s allegations, including that the hospital trips were retaliatory; the dispute highlights the difficult choices families face when facilities recommend antipsychotic drugs for residents with dementia.
In December 2024, Vista Grande Villa emailed Tingley’s adult sons that their 85-year-old mother posed a serious safety threat. Facility behavior logs recorded that on at least 10 days in the prior month, she hit, kicked or elbowed aides helping her change briefs, dress, bathe or use the bathroom. The facility sought the family’s permission to sedate her, according to KFF Health News’ account of the records.
The family and facility disagreed over medication as incidents continued. Records show Tingley was taken to an emergency room eight times after episodes of aggressive behavior. After four visits, Vista Grande gave her a 30-day eviction notice; she was sent to the hospital four more times while the family arranged another placement. Her sons’ lawsuit alleges the facility initiated the emergency visits in retaliation for their disagreements over her care. Vista Grande and its director deny that allegation. In a legal filing, the facility said it sent Tingley to the hospital because her family would not allow her to be treated on site.
Tingley died at another facility in January 2025. Her sons’ suit accuses Vista Grande and its former director of negligence, causing emotional distress and wrongful eviction. A judge dismissed the negligence claim on legal grounds. A trial on the remaining claims is scheduled for early next year if mediation does not resolve the case. Vista Grande’s attorneys and the former director did not respond to the news outlet’s requests for comment. The facility later became a wholly owned subsidiary of Otterbein SeniorLife and was renamed Otterbein Jackson SeniorLife Community; Otterbein is not named in the suit.
Medication Choices in Memory Care
The case puts a practical dilemma in view: medication may be proposed to manage behavior that puts residents or staff at risk, while antipsychotic drugs carry serious risks for older people with dementia. Families who object may worry about sedation and other harms, yet face the possibility that a facility will say it cannot safely care for their relative. The lawsuit concerns one family and one facility; its claims have not been resolved at trial.
The scale of prescribing makes the question relevant beyond Tingley’s case. More than 5 million Medicare beneficiaries have a dementia diagnosis. A JAMA study estimated that one in four Medicare beneficiaries with dementia may be inappropriately prescribed antipsychotics or other brain-altering medications that can cause delirium, falls and hospitalizations. The estimate covers those medication types together; it does not mean every prescription is inappropriate or that every patient faces the same outcome.
Facilities also have to manage episodes that can put residents and care workers at risk. A decision about medication can affect a resident’s alertness and safety, but so can an unresolved cause of agitation or a care arrangement that cannot meet the resident’s needs. The records described in this case show how disagreements over treatment can become intertwined with emergency care and a resident’s continued place in a facility.
Why Dementia Can Cause Agitation
Dementia can damage brain areas involved in impulse control and perception. A person who does not recognize a caregiver may respond with fear; someone in pain, hungry or unable to express another need may become agitated. Those behaviors can occur during intimate care, including bathing, dressing or using the bathroom, as the facility logs say happened with Tingley.
Antipsychotics are approved by the Food and Drug Administration primarily for conditions such as schizophrenia. The FDA requires manufacturers to warn that these drugs increase the risk of death in older people with Alzheimer’s and similar diseases. That warning does not establish what caused any particular patient’s outcome, and the source report does not attribute Tingley’s death to medication. Her reported cause of death was plaque buildup in her brain, a hallmark of Alzheimer’s disease.
Federal efforts to reduce prescribing have been underway for years. In 2012, the Centers for Medicare & Medicaid Services launched the Partnership to Improve Dementia Care. The campaign has reduced antipsychotic use in nursing homes, but the KFF report cites a 2025 estimate that, excluding people with schizophrenia, antipsychotics were still given to one in seven nursing home residents. That measure concerns nursing home residents; it should not be read as a rate for all memory care facilities.
““They just wanted to have her drugged up.””
— David Tingley, one of Marjorie Tingley’s sons
Disputed Reasons for Hospital Trips
The central dispute remains unresolved: the family says the emergency room trips were retaliatory, while Vista Grande says it sent Tingley to the hospital because the family declined treatment at the facility. The records establish that she made eight trips, but the lawsuit’s allegation about why they were initiated has not been decided in court.
The negligence claim was dismissed on legal grounds, but the source report does not provide the judge’s full reasoning. It also does not establish whether the medication was administered, what specific drug or dose was proposed, or how much it affected Tingley’s behavior. Vista Grande’s attorneys and former director did not respond to requests for comment, and Otterbein SeniorLife did not comment. The facility and its former director have denied the allegations.
Remaining Claims Await Court
The remaining lawsuit claims are scheduled for trial early next year if mediation fails. The outcome could clarify the disputed allegations about the hospital trips and eviction. Until then, those claims remain allegations, and the facility’s account remains its position in the legal filing. The source report does not specify a trial date or say whether mediation has been scheduled.
For families considering treatment in memory care, the case also leaves practical questions about how facilities explain medication recommendations, document incidents and respond when relatives disagree. The source material does not describe new regulations or policy changes resulting from the lawsuit. Any broader effect will depend on the court proceedings and on decisions by care providers and regulators.
Key Questions
Why did Vista Grande seek permission to medicate Tingley?
The facility said Tingley posed a serious safety threat after behavior logs recorded that she hit, kicked or elbowed aides on at least 10 days in one month while they helped with personal care. Her sons and the facility disagreed over whether medication was appropriate.
What does the family’s lawsuit allege?
The suit accuses Vista Grande and its former director of negligence, causing emotional distress and wrongful eviction. It also alleges the facility initiated emergency room trips in retaliation for disagreements about Tingley’s care. Vista Grande and the former director deny the allegations.
Did the court decide the family’s allegations?
A judge dismissed the negligence claim on legal grounds. The remaining claims are scheduled for trial early next year if mediation fails, so the dispute over the hospital trips and eviction has not been resolved in court.
What risks are associated with antipsychotic drugs for older people with dementia?
The FDA requires manufacturers to warn that antipsychotics increase the risk of death in older people with Alzheimer’s and similar diseases. The KFF report also describes risks from antipsychotics and other brain-altering medications, including delirium, falls and hospitalizations. A clinician should discuss treatment decisions with the patient or their representative.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
